Prelude Therapeutics (PRLD)
(Delayed Data from NSDQ)
$3.45 USD
-0.15 (-4.17%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $3.41 -0.04 (-1.16%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.46 | 0.00% |
Earnings Summary
For their last quarter, Prelude Therapeutics (PRLD) reported earnings of -$0.42 per share, beating the Zacks Consensus Estimate of $-0.47 per share. This reflects a positive earnings surprise of 10.64%. Look out for PRLD's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.46 per share, reflecting a year-over-year increase of 14.81%.
Earnings History
Price & Consensus
Zacks News for PRLD
All You Need to Know About Prelude Therapeutics Incorporated (PRLD) Rating Upgrade to Buy
PRLD: What are Zacks experts saying now?
Zacks Private Portfolio Services